| CCMAX | PEMGX | CCMAX / PEMGX | |
| Total Expense Ratio | 0.80 | 0.91 | 88% |
| Annual Report Gross Expense Ratio | 8.73 | 0.91 | 959% |
| Fund Existence | 4 years | 20 years | - |
| Gain YTD | -2.201 | 2.065 | -107% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 250000 | 1000 | 25,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.77M | 31.6B | 0% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -9.33 | -7.41 | 126% |
| Returns for 3 years | 17.65 | 32.06 | 55% |
| Returns for 5 years | N/A | 25.07 | - |
| Returns for 10 years | N/A | 94.30 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FTXH | 32.75 | 0.38 | +1.18% |
| First Trust Nasdaq Pharmaceuticals ETF | |||
| AIRR | 98.68 | 1.01 | +1.03% |
| First Trust RBA Amer Indl RenaisTM ETF | |||
| VLU | 210.46 | 1.45 | +0.69% |
| State Street® SPDR® S&P® 1500 ValTiltETF | |||
| IHYF | 22.67 | 0.05 | +0.22% |
| Invesco High Yield Bond Factor ETF | |||
| CPRJ | 26.67 | 0.05 | +0.20% |
| Calamos Russell 2000 Str Alt Prt ETF-Jul | |||